Skip to main content

Mar Tintore Subirana

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC) and since October 2022 I have been Chair of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Clinical neuroimmunology
General Hospital
Responsable Assistencial
Multiple Sclerosis Centre of Catalonia

Mar Tintore Subirana

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Clinical neuroimmunology
General Hospital
Responsable Assistencial
Multiple Sclerosis Centre of Catalonia

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC) and since October 2022 I have been Chair of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

I have developed in particular the study of prognostic factors, multiple sclerosis of the child and adolescent, as well as family planning in women with multiple sclerosis. I am currently a member of the Advisory Ethics Committee (CEA) of the Vall d'Hebron University Hospital.

I have published more than 260 articles in national and international journals and am a regular reviewer of indexed journals both national and international. My factor H is currently 60 and until May 2023 my work has received 15,464 citations.

Projects

UNiC-Unitat de Neuroimmunologia Clínica

IP: Xavier Montalban Gairín
Collaborators: Carlos Nos Llopis, Jordi Rio Izquierdo, Manuel Comabella Lopez, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Mireia Castillo Juarez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 35600
Reference: 2005SGR 01081
Duration: 01/01/2006 - 31/12/2008

Estudio de la función de las células dentríticas (CD) en la esclerosis múltiple (EM). Diferencias entre las distintas formas clínicas de la enfermedad.

IP: Mar Tintore Subirana
Collaborators: Jordi Rio Izquierdo, Manuel Comabella Lopez
Funding agency: Instituto de Salud Carlos III
Funding: 31740
Reference: PI020158
Duration: 06/11/2002 - 06/11/2005

Related news

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Related professionals

Rocío Piñera Moreno

Rocío Piñera Moreno

Research assistant
Gene and Cell Therapy
Read more
Joana Margalida Cladera  Sastre

Joana Margalida Cladera Sastre

Research technician
Neurodegenerative Diseases
Read more
Kushal Mukesh Lakhani Mahtani

Kushal Mukesh Lakhani Mahtani

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Deepak Chauhan

Deepak Chauhan

Postdoctoral researcher
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.